Diamond Biotechnology Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Diamond Biotechnology Co Ltd

Watchlist Manager

Watchlist

Price: 24 TWD -1.03% Market Closed

Market Cap: NT$953m

D	Diamond Biotechnology Co Ltd TPEX:6815	TW
	Banan Real Estate Company SJSC SAU:9519	SA
C	Carbon Group SA WSE:ELM	PL
	Imasen Electric Industrial Co Ltd OTC:IMSNF	JP
S	Sejong Medical Co Ltd KOSDAQ:258830	KR
	XcelMobility Inc OTC:XCLL	US
	Walkabout Resources Ltd F:N6D	AU
	Faith Inc TSE:4295	JP

Profitability Summary

Diamond Biotechnology Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

40%

Sustainable 3Y Average Gross Margin

44%

Declining Gross Margin

43% > 40%

Low Operating Margin

Sustainable 3Y Average Operating Margin

11%

Declining Operating Margin

12% > 7%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

9% > 5%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-6%

Free Cash Flow Margin is Increasing

-9% > 8%

Low ROE

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.